| 标题 |
 Effect of CagriSema 2.4mg/2.4mg on Body Composition, Muscle Strength & Physical Function: REDEFINE 1 |
| 网址 | |
| DOI | |
| 其它 |
期刊：Obesity 作者：Of the 808,000 dialysis patients in the US; 60% have diabetes and are potentially eligible for glucagon-like peptide-1 (GLP-1) receptor agonist treatment. Their safety and outcomes in this population is unknown. The objective of this study was to examine GLP-1 receptor agonist real-world safety; efficacy; and weight loss extent in people with diabetes on dialysis. 出版日期：2025-11-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
散逸层梦游
吃葡萄不吐葡萄皮
学术雷锋
渡人舟
Criminology34
北白川anko
飘逸的大雁
sanvva
Chinlu_Lee
v0id
年年有余
123
madeleinli
sxlen
无极微光
学霸业
GingerF
Jadyn_GU
CRUSADER
皖公网安备34019202002308
